What are Amphastar Pharmaceuticals's profit margins?

Amphastar Pharmaceuticals (AMPH) runs a 47.3% gross margin and a 16.2% operating margin, with a 11.0% net margin.

Where do Amphastar Pharmaceuticals's ratios come from?

Every ratio is computed from Amphastar Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Amphastar Pharmaceuticals AMPH Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Gross margin	49.5%-1.6pp	51.1%-3.4pp	54.5%+4.6pp	49.9%+4.2pp
Operating margin	19.5%-8.6pp	28.1%-2.5pp	30.6%+9.0pp	21.5%+5.6pp
Net margin	13.6%-8.2pp	21.8%+0.4pp	21.3%+3.0pp	18.3%+4.1pp
EBITDA margin	27.4%-7.9pp	35.3%-1.2pp	36.5%+10.0pp	26.5%+5.2pp
Free cash flow margin	16.8%-6.7pp	23.5%+1.0pp	22.6%+8.9pp	13.7%-3.5pp
Returns
Return on assets	6.1%-4.2pp	10.3%-1.9pp	12.2%-0.7pp	12.9%+3.4pp
Efficiency
Asset turnover	0.4×0.0×	0.5×-0.1×	0.6×-0.1×	0.7×0.0×
Inventory turnover	2.2×-0.6×	2.8×0.0×	2.8×+0.3×	2.5×0.0×
Liquidity
Current ratio	4×+0.9×	3.1×+0.9×	2.2×-1.8×	4×+0.9×
Quick ratio	2.9×+0.7×	2.2×+0.5×	1.7×-1.2×	2.9×+0.7×
Cash ratio	1.1×+0.2×	0.9×+0.2×	0.6×-1.0×	1.6×+0.4×
Leverage
Debt-to-assets	0.4×0.0×	0.4×0.0×	0.4×+0.3×	0.1×0.0×
Net debt / EBITDA	2.5×+0.5×	1.9×-0.1×	2×+2.4×	-0.4×-0.2×
Interest coverage	5.5×-1.3×	6.8×-0.5×	7.3×-51.0×	58.2×-20.7×
Valuation
Market capitalization	$927.72M-19.9%	$1.79B-39.7%	$2.96B+119%	$1.35B+21.5%
Enterprise value	$1.44B-11.3%	$2.28B-33.6%	$3.44B+165%	$1.3B+19.1%
Price / earnings	11.7×+3.5×	11.2×-10.4×	21.5×+6.7×	14.8×-3.1×
Price / sales	1.3×-0.3×	2.4×-2.2×	4.6×+1.9×	2.7×+0.2×
EV / EBITDA	8.3×+1.7×	8.8×-5.8×	14.6×+4.8×	9.8×-1.9×
EV / sales	2×-0.2×	3.1×-2.2×	5.3×+2.7×	2.6×+0.1×
Free cash flow yield	14.6%+1.6pp	9.7%+4.7pp	4.9%-0.1pp	5%-1.7pp
Earnings yield	8.5%-3.7pp	8.9%+4.3pp	4.6%-2.1pp	6.7%+1.2pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Amphastar Pharmaceuticals.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Amphastar Pharmaceuticals's profit margins?: Amphastar Pharmaceuticals (AMPH) runs a 47.3% gross margin and a 16.2% operating margin, with a 11.0% net margin.
Where do Amphastar Pharmaceuticals's ratios come from?: Every ratio is computed from Amphastar Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.